Delivery Order SPE2DB20D2104-SPE2DB25FNBRF
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through...
- The Defense Logistics Agency (DLA) awarded a $3,134.47 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,853.70. This non-set-aside award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,481.34 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) under a firm fixed-price contract valued at $10,801.96, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Qulipta 60 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,568.63. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- The Defense Logistics Agency awarded a $1,420.07 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Qulipta 60 mg tablets (30-count). This firm fixed-price, non-set-aside contract is scheduled for completion by July 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $2,309.58 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...